Sign up to save your podcasts
Or
Share Risk Management for Biotech Companies in Clinical Trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Risk Management for Biotech Companies in Clinical Trials
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
- How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
You can learn more at https://q2labsolutions.com/biotech.
View all episodes
By Q Squared Solutions
5
55 ratings
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
- How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
You can learn more at https://q2labsolutions.com/biotech.